Structured view
Meridian Royalty TrustSP-2025-03-04-MRT-MDA-22910
Meridian Royalty Trust
888 3rd Street SW, Suite 2400, Calgary, AB T2P 5C5
Form 51-102F1 — Management's Discussion & Analysis

Management's Discussion & Analysis — Year ended December 31, 2024

For the period ended December 31, 2024
Principal regulator: Alberta Securities Commission

1.Date

This Management's Discussion and Analysis ("MD&A") of Meridian Royalty Trust (the "Company") is dated March 4, 2025 and should be read in conjunction with the Company's financial statements for the period ended December 31, 2024, together with the notes thereto.

2.Cautionary Note Regarding Forward-Looking Information

Certain statements in this MD&A constitute forward-looking information within the meaning of applicable Canadian securities laws. Forward-looking information reflects the Company's current expectations regarding future events and operating performance and speaks only as of the date of this MD&A. Readers are cautioned not to place undue reliance on forward-looking information. The Company undertakes no obligation to update forward-looking information except as required by applicable securities laws.

3.Overall Performance

Royalty revenue for the year was $214.6 million across 28 producing streams.

The Trust declared distributions of $1.12 per unit, consistent with prior guidance.

4.Selected Quarterly Information

Amounts in Canadian dollars.
QuarterRevenueOp. exp.G&ANet income (loss)Cash on hand
Q4 2024$1,930,409$1,172,203$357,653$300,554$1,634,864
Q4 2024$1,944,948$1,133,698$321,684$389,566$965,265
Q3 2024$1,805,009$1,076,414$329,280$299,315$1,602,832
Q1 2024$1,567,129$1,063,372$270,847$132,910$1,367,635
Q4 2023$1,465,597$843,921$240,340$281,336$996,810
Q4 2023$1,351,021$948,434$197,085$105,502$1,122,266

5.Results of Operations

Revenue for the period was $1,930,409, compared with $1,944,948 in the immediately preceding quarter and $1,465,597 in the comparative quarter of the prior year. Operating expenses were $1,172,203, reflecting the mix of activities described under "Overall Performance" above. General and administrative expenses of $357,653 include professional fees, salaries and public-company costs. The Company reported a net result of $300,554 for the period.

6.Liquidity

As at December 31, 2024, the Company had cash and cash equivalents of $1,634,864. Management continues to monitor working capital requirements and expects existing cash resources, together with cash generated from operations and access to committed credit facilities, to be sufficient to fund planned activities for the twelve months following the date of this MD&A.

7.Capital Resources

The Company's capital structure consists of common shares, stock options and any drawings under its credit facilities. There have been no material changes to the Company's capital resources during the period other than as disclosed elsewhere in this MD&A. The Company is not subject to any externally imposed capital requirements.

8.Off-Balance-Sheet Arrangements

The Company has no off-balance-sheet arrangements that have or are reasonably likely to have a current or future material effect on its financial condition, results of operations, liquidity or capital resources.

9.Transactions with Related Parties

Related-party transactions during the period were undertaken in the normal course of business and are measured at the exchange amount agreed to by the parties. Compensation of key management personnel is disclosed in the notes to the financial statements.

10.Critical Accounting Estimates and Risk Factors

The preparation of financial statements in accordance with IFRS requires management to make estimates and assumptions that affect the reported amounts of assets, liabilities, revenues and expenses. Actual results may differ from those estimates. The Company's business is subject to risks and uncertainties that are described in the Company's most recent Annual Information Form under "Risk Factors".

11.Approval

The board of directors of Meridian Royalty Trust has approved the disclosure contained in this MD&A. A copy of this MD&A and the related financial statements will be provided to any shareholder who requests it.

/s/ Sandra Fitzgerald
Chief Executive Officer
March 4, 2025
/s/ Michael O'Rourke
Chief Financial Officer
March 4, 2025
MD&A · March 4, 2025Page 1 of 1